Abstract

Purpose: Every year, an increasing number of international patients seek medical care in the United States (U.S.), yet little is known about their impact. Based on single institution experiences, we wanted to explore the perceived impact of international pediatric patients on large academic U.S. pediatric intensive care units (PICUs), as they are already taxed systems.Methods: To explore current perceptions, seven geographically diverse institutions who advertise care for international patients on their websites and have ≥24 PICU beds were identified after IRB approval was obtained. We consented and interviewed PICU division chiefs or medical directors from each institution regarding their demographics and international patients. Common themes were identified.Results: Participating institutions were diverse in geographic location, census, and resource allocation strategies. Five of the seven institutions reported the presence of a formal international patient program. Four of those five reported an increase in international patients receiving PICU care over the past 5 years. International patients sought complex surgeries, advanced cancer treatments and metabolic/genetic evaluations. We identified three primary domains that require further exploration and research: (1) cultural and language differences leading to barriers in providing optimal care to international patients (2) institutional financial considerations, and (3) perceived positive and negative impact on the care of local/domestic patient populations.Conclusions: The presence of international programs raises a number of important ethical questions, including whether clinicians have a greater duty to serve residents of the local community as opposed to international patients when resources are limited. Further exploration is warranted.

Highlights

  • A family from another country brings their 7-year-old son to an academic pediatric institution in the United States for experimental chimeric antigen receptor T-cell therapy for refractory leukemia

  • He develops multi-organ failure requiring extracorporeal life support (ECLS). He dies based on neurological criteria (“brain death”), but the embassy of his home country refuses to allow discontinuation of ECLS

  • Four pediatric intensive care unit (PICU) division chiefs and three PICU medical directors participated from seven distinct sites

Read more

Summary

Introduction

A family from another country brings their 7-year-old son to an academic pediatric institution in the United States for experimental chimeric antigen receptor T-cell therapy for refractory leukemia. During his hospitalization, he develops multi-organ failure requiring extracorporeal life support (ECLS). International patients are often referred to as medical tourists or international medical travelers in the literature. For the purpose of this paper, we narrowly define “international patients” as patients from other countries who seek inpatient care from an institution in the U.S for a novel or otherwise unavailable therapy, who plan to return to their home country after treatment

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call